Measuring the Value of Prescription Drugs
N Engl J Med
.
2015 Dec 31;373(27):2595-7.
doi: 10.1056/NEJMp1512009.
Epub 2015 Nov 18.
Authors
Peter J Neumann
1
,
Joshua T Cohen
Affiliation
1
From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston.
PMID:
26580666
DOI:
10.1056/NEJMp1512009
No abstract available
MeSH terms
Cost-Benefit Analysis*
Humans
Prescription Drugs / economics*
Prescription Drugs / therapeutic use
Quality-Adjusted Life Years
Societies, Medical
United States
Substances
Prescription Drugs